NCT00046618

Brief Summary

To identify new dilated cardiomyopathy genes by genetic linkage and mutational analyses.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Jul 2002

Longer than P75 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2002

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 30, 2002

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 1, 2002

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2006

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2006

Completed
Last Updated

February 20, 2014

Status Verified

February 1, 2014

Enrollment Period

3.9 years

First QC Date

September 30, 2002

Last Update Submit

February 19, 2014

Conditions

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
No eligibility criteria

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Related Publications (1)

  • Olson TM, Michels VV, Ballew JD, Reyna SP, Karst ML, Herron KJ, Horton SC, Rodeheffer RJ, Anderson JL. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA. 2005 Jan 26;293(4):447-54. doi: 10.1001/jama.293.4.447.

    PMID: 15671429BACKGROUND

MeSH Terms

Conditions

Cardiomyopathy, DilatedCardiovascular DiseasesHeart DiseasesHeart Failure

Condition Hierarchy (Ancestors)

CardiomegalyCardiomyopathiesLaminopathiesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Timothy Olson

    Mayo Clinic

Study Design

Study Type
observational
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 30, 2002

First Posted

October 1, 2002

Study Start

July 1, 2002

Primary Completion

June 1, 2006

Study Completion

June 1, 2006

Last Updated

February 20, 2014

Record last verified: 2014-02